Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halliburton Company (HAL) vs Select Medical Holdings Corporation (SEM) Price & Performance

Halliburton CompanyTrade
Select Medical Holdings CorporationTrade

Price performance (Past 24H)

Key statistics

Halliburton Company vs Select Medical Holdings Corporation — how do they compare? Halliburton Company trades at $32.86 (market cap $29.33B), while Select Medical Holdings Corporation trades at $16.51 (market cap $2.05B). The key difference: Halliburton Company is far larger — about 14.3× Select Medical Holdings Corporation's market cap, and Halliburton Company pays the higher dividend (1.94%). Which is the better fit depends on your goals.

HALSEM
Market Cap
$29.33B$2.05B
Sector
EnergyHealth
52-Week High
$42.98$16.66
52-Week Low
$20.50$11.77
Enterprise Value
$35.41B$5.01B
Dividend Yield
1.94%1.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Halliburton Company

Halliburton (HAL) trades at $35.56, up 0.97% on the day, with a bullish technical signal supported by moving averages. The company shows solid fundamentals with a P/E of 19.46 and ROE of 14.56%, though net income declined to $1.28B in 2025. Recent contract wins with Aramco in Saudi Arabia and TotalEnergies in Suriname highlight growth opportunities, while analyst consensus is strongly bullish with a $44.78 price target.

Outlook remains positive due to strategic contracts and oil price support from geopolitical tensions, but risks include Middle East volatility and cost pressures. The stock offers value with earnings beats and institutional backing, though investors should monitor debt levels and execution on new projects.

Select Medical Holdings Corporation

Select Medical Holdings Corporation (SEM) trades at $16.51, unchanged on the day, following its recent acquisition completion by a consortium led by Robert A. Ortenzio and Martin F. at $16.50 per share. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported 2025 revenue of $5.45 billion with a net income margin of 2.42%, while valuation ratios like a P/E of 15.43 and P/S of 0.36 appear reasonable. Recent earnings show two misses in the last three quarters against expectations.

The investment outlook is dominated by the completed acquisition, effectively capping upside near the $16.50 deal price. Risks include ongoing shareholder litigation alleging fiduciary breaches by the board regarding the buyout fairness. Analyst sentiment is neutral with a Hold-heavy consensus, while the stock's future price action will largely hinge on legal outcomes surrounding the acquisition terms rather than operational performance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Halliburton Company

Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.

Read more on HAL

About Select Medical Holdings Corporation

Select Medical Holdings Corporation is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's services focus on treating patients with serious illnesses, injuries, and post-acute care needs. SEM provides specialized care across various settings, aiming to help patients recover and return home.

Read more on SEM